Evidence map›Paper›PMID 40840647›Full record

ArticleExperimental eye research2025

Analysis of mouse lens morphological and proteomic abnormalities following deletion of the βB3-crystallin promoter.

Danielle Rayêe, Phillip A Wilmarth, Judy K VanSlyke, Keith Zientek, Ashok P Reddy, Linda S Musil, Larry L David, Aleš Cvekl

Abstract read
In one paragraph

Article in Experimental eye research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Danielle RayêeDepartments of Ophthalmology and Visual Sciences and Genetics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Phillip A WilmarthProteomics Shared Resource, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Judy K VanSlykeDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Keith ZientekProteomics Shared Resource, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Ashok P ReddyProteomics Shared Resource, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Linda S MusilDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Larry L DavidProteomics Shared Resource, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA; Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.
Aleš CveklDepartments of Ophthalmology and Visual Sciences and Genetics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. Electronic address: ales.cvekl@einsteinmed.edu.

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI Ulrich Steidl · 1985 to 2026
$111.2M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
Transcriptional Control of the Mouse aA-crystallin locusR01EY014237 · NEI · YESHIVA UNIVERSITY · PI Ales Cvekl · 2003 to 2026
$11.0M
LTQ Orbitrap VelosS10OD012246 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID, LARRY L · 2012 to 2012
$854k
NCI NIH HHS P30 CA013330NCI NIH HHS P30 CA069533NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY014237NIH HHS S10 OD012246
6 · The paper itself

Abstract

Crystallin proteins serve as both essential structural and as well as protective components of the ocular lens and are required for the transparency and light refraction properties of the organ. The mouse lens crystallin proteome is represented by αA-, αB-, βA1-, βA2-, βA3-, βA4-, βB1-, βB2-, βB3-, γA-, γB-, γC-, γD-, γE, γF-, γN-, and γS-crystallin proteins encoded by 16 genes. Their mutations are responsible for lens opacification and early onset cataract formation. While many cataract-causing missense and nonsense mutations are known for these genes, including the human CRYBB3 gene, the mammalian loss-of function model of Crybb3 remains to be established. Herein, we generated the first mouse model via deletion of the Crybb3 promoter that nearly abolished expression of the βB3-crystallin. Histological analysis of lens morphology using newborn βB3-crystallin-deficient lenses revealed disrupted lens morphology with early-onset phenotypic variability. In-depth lens proteomics at four time points (newborn, 3-weeks, 6-weeks, and 3-months) showed both down- and up-regulation of various proteins, with the highest divergence from control mice observed in 3-months lenses. Apart from the βB3-crystallin, Smarcc1/Baf155 was down-regulated in all four stages. In addition, downregulation of Hspe1, Pdlim1, Ast/Got, Lsm7, Ddx23, and Acad11 was found in three time points. Finally, we show that the βB3-crystallin promoter region, which contains multiple binding sites for the transcription factors AP-2α, c-Jun, c-Maf, Etv5, and Pax6 is activated by FGF2 in primary lens cell culture experiments. Together, these studies establish the mouse Crybb3 loss-of-function model and its disrupted crystallin and non-crystallin proteomes.

Indexed as

beta-Crystallin B ChainCataractLens, CrystallinePromoter Regions, GeneticProteomeProteomicsAnimalsAnimals, NewbornBlotting, WesternDisease Models, AnimalMiceMice, Inbred C57BLbeta-Crystallin B ChainProteomeCataractCytoplasmIsobaric labelingLensProteomesQuantitative proteomicsβB3-crystallin

Identifiers

PMID40840647
PMCPMC13587758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.